Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Onconetix (ONCO) Preferred Stock Liabilities (2023 - 2025)

Historic Preferred Stock Liabilities for Onconetix (ONCO) over the last 3 years, with Q3 2025 value amounting to $1.7 million.

  • Onconetix's Preferred Stock Liabilities changed N/A to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year change of. This contributed to the annual value of $1.1 million for FY2024, which is 9833.75% down from last year.
  • According to the latest figures from Q3 2025, Onconetix's Preferred Stock Liabilities is $1.7 million.
  • Onconetix's Preferred Stock Liabilities' 5-year high stood at $64.2 million during Q4 2023, with a 5-year trough of $443443.0 in Q2 2025.
  • Over the past 3 years, Onconetix's median Preferred Stock Liabilities value was $1.7 million (recorded in 2025), while the average stood at $28.1 million.
  • Its Preferred Stock Liabilities has fluctuated over the past 5 years, first plummeted by 9833.75% in 2024, then crashed by 9930.97% in 2025.
  • Onconetix's Preferred Stock Liabilities (Quarter) stood at $64.2 million in 2023, then tumbled by 98.34% to $1.1 million in 2024, then surged by 59.19% to $1.7 million in 2025.
  • Its last three reported values are $1.7 million in Q3 2025, $443443.0 for Q2 2025, and $524449.0 during Q1 2025.